We investigated serum BCAR1 levels in 80 NSCLC cases and 80 healthy controls, respectively, by using a specific enzyme-linked immunosorbent assay (ELISA) [9]. This evidence concerns the gene BCAR1 and non-small cell lung carcinoma.